About AmpliPhi Biosciences Corp.

Develops and commercializes novel bacteriophage-based therapeutics

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -0.55$ per share.

The book value per share is 0.51$

AmpliPhi Biosciences Corp. website


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -10M - -10M -0.55 - - 14M 0.51 -9M - -9M